Administration of oral methylphenidate during adolescence prevents suppressive development of dopamine projections into prefrontal cortex and amygdala after an early pharmacological challenge in gerbils

Brain Research

Volumn 1176, Issue 1, 2007, Pages 124-132

  Grund, Thorsten ^a   Teuchert Noodt, Gertraud ^a   Busche, Andrea ^a   Neddens, Jörg ^a   Brummelte, Susanne ^a   Moll, Gunther H ^b   Dawirs, Ralph R ^a,b  

^a BIELEFELD UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

ADHD; Attention deficit hyperactivity disorder; Dopamine; Methamphetamine; Ritalin

Indexed keywords

DOPAMINE; METHYLPHENIDATE;

AMYGDALOID NUCLEUS; ANALYSIS OF VARIANCE; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; GERBIL; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; POSTNATAL DEVELOPMENT; PREFRONTAL CORTEX; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; AGING; AMYGDALA; ANIMALS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; GERBILLINAE; GROWTH CONES; MALE; METHYLPHENIDATE; NEURAL PATHWAYS; NEUROGENESIS; PREFRONTAL CORTEX; VENTRAL TEGMENTAL AREA;

ANIMALIA; GERBILLINAE;

EID: 35148820653     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2007.06.107     Document Type: Article

References (65)

1. Andersen S.L. Stimulants and the developing brain. Trends Pharmacol. Sci. 26 (2005) 237-243
2. Andersen S.L., and Navalta C.P. Altering the course of neurodevelopment: a framework for understanding the enduring effects of psychotropic drugs. Int. J. Dev. Neurosci. 22 (2004) 423-440
3. Benes F.M., Paskevich P.A., Davidson J., and Domesick V.B. The effects of haloperidol on synaptic patterns in the rat striatum. Brain Res. 329 (1985) 265-273
4. Berger A., and Posner M.I. Pathologies of brain attentional networks. Neurosci. Biobehav. Rev. 24 (2000) 3-5
5. Blaesing B., Nossoll M., Teuchert-Noodt G., and Dawirs R.R. Postnatal maturation of prefrontal pyramidal neurones is sensitive to a single early dose of methamphetamine in gerbils (Meriones unguiculatus). J. Neural Transm. 108 (2001) 101-113
6. Bolanos C.A., Barrot M., Berton O., Wallace-Black D., and Nestler E.J. Methylphenidate treatment during pre- and periadolescence alters behavioral responses to emotional stimuli at adulthood. Biol. Psychiatry 54 (2003) 1317-1329
7. Brummelte S., Neddens J., and Teuchert-Noodt G. Alteration in the GABAergic network of the prefrontal cortex in a potential animal model of psychosis. J. Neural Transm. 114 5 (2007) 539-547
8. Busche A., Neddens J., Dinter C., Dawirs R.R., and Teuchert-Noodt G. Differential influence of rearing conditions and methamphetamine on serotonin fibre maturation in the dentate gyrus of gerbils (Meriones unguiculatus). Dev. Neurosci. 24 (2002) 512-521
9. Carlezon Jr. W.A., Mague S.D., and Andersen S.L. Enduring behavioral effects of early exposure to methylphenidate in rats. Biol. Psychiatry 54 (2003) 1330-1337
10. Challman T.D., and Lipsky J.J. Methylphenidate: its pharmacology and uses. Mayo Clin. Proc. 75 (2000) 711-721
11. Crawford C.A., Villafranca S.W., Cyr M.C., Farley C.M., Reichel C.M., Gheorghe S.L., Krall C.M., and McDougall S.A. Effects of early methylphenidate exposure on morphine- and sucrose-reinforced behaviors in adult rats: relationship to dopamine D2 receptors. Brain Res. 1139 (2007) 245-253
12. Cunningham M.G., Bhattacharyya S., and Benes F.M. Amygdalo-cortical sprouting continues into early adulthood: implications for the development of normal and abnormal function during adolescence. J. Comp. Neurol. 453 (2002) 116-130
13. Dawirs R.R., Teuchert-Noodt G., and Czaniera R. The postnatal maturation of dopamine innervation in the prefrontal cortex of gerbils (Meriones unguiculatus) is sensitive to an early single dose of methamphetamine. A quantitative immunocytochemical study. J. Hirnforsch. 35 (1994) 195-204
14. Dawirs R.R., Teuchert-Noodt G., and Czaniera R. Ontogeny of PFC-related behaviours is sensitive to a single non-invasive dose of methamphetamine in neonatal gerbils (Meriones unguiculatus). J. Neural Transm. 103 (1996) 1235-1245
15. Denney C.B. Stimulant effects in attention deficit hyperactivity disorder: theoretical and empirical issues. J. Clin. Child Psychol. 30 (2001) 98-109
16. Ding Y.S., Gatley S.J., Thanos P.K., Shea C., Garza V., Xu Y., Carter P., King P., Warner D., Taintor N.B., Park D.J., Pyatt B., Fowler J.S., and Volkow N.D. Brain kinetics of methylphenidate (Ritalin) enantiomers after oral administration. Synapse 53 (2004) 168-175
17. Dinn W.M., Robbins N.C., and Harris C.L. Adult attention-deficit/hyperactivity disorder: neuropsychological correlates and clinical presentation. Brain Cogn. 46 (2001) 114-121
18. Ernst M., Kimes A.S., London E.D., Matochik J.A., Eldreth D., Tata S., Contoreggi C., Leff M., and Bolla K. Neural substrates of decision making in adults with attention deficit hyperactivity disorder. Am. J. Psychiatry 160 (2003) 1061-1070
19. Federici M., Geracitano R., Bernardi G., and Mercuri N.B. Actions of methylphenidate on dopaminergic neurons of the ventral midbrain. Biol. Psychiatry 57 (2005) 361-365
20. Fuster J.M. The prefrontal cortex and its relation to behavior. Prog. Brain Res. 87 (1991) 201-211
21. Garland E.J. Pharmacotherapy of adolescent attention deficit hyperactivity disorder: challenges, choices and caveats. J. Psychopharmacol. 12 (1998) 385-395
22. Gerasimov M.R., Franceschi M., Volkow N.D., Gifford A., Gatley S.J., Marsteller D., Molina P.E., and Dewey S.L. Comparison between intraperitoneal and oral methylphenidate administration: a microdialysis and locomotor activity study. J. Pharmacol. Exp. Ther. 295 (2000) 51-57
23. Goldman L.S., Genel M., Bezman R.J., and Slanetz P.J. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association. JAMA 279 (1998) 1100-1107
24. Hildebrandt K., Teuchert-Noodt G., and Dawirs R.R. A single neonatal dose of methamphetamine suppresses dentate granule cell proliferation in adult gerbils which is restored to control values by acute doses of haloperidol. J. Neural Transm. 106 (1999) 549-558
25. Hyman S.E. Methylphenidate-induced plasticity: what should we be looking for?. Biol. Psychiatry 54 (2003) 1310-1311
26. Ikemoto S., and Panksepp J. The role of nucleus accumbens dopamine in motivated behavior: a unifying interpretation with special reference to reward-seeking. Brain Res. Brain Res. Rev. 31 (1999) 6-41
27. Jensen P.S., Hinshaw S.P., Swanson J.M., Greenhill L.L., Conners C.K., Arnold L.E., Abikoff H.B., Elliott G., Hechtman L., Hoza B., March J.S., Newcorn J.H., Severe J.B., Vitiello B., Wells K., and Wigal T. Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): implications and applications for primary care providers. J. Dev. Behav. Pediatr. 22 (2001) 60-73
28. Kelley A.E., and Berridge K.C. The neuroscience of natural rewards: relevance to addictive drugs. J. Neurosci. 22 (2002) 3306-3311
29. Kirby K., Rutman L.E., and Bernstein H. Attention-deficit/hyperactivity disorder: a therapeutic update. Curr. Opin. Pediatr. 14 (2002) 236-246
30. Kuczenski R., and Segal D.S. Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: comparison with amphetamine. J. Neurochem. 68 (1997) 2032-2037
31. Kuczenski R., and Segal D.S. Locomotor effects of acute and repeated threshold doses of amphetamine and methylphenidate: relative roles of dopamine and norepinephrine. J. Pharmacol. Exp. Ther. 296 (2001) 876-883
32. Kuczenski R., and Segal D.S. Exposure of adolescent rats to oral methylphenidate: preferential effects on extracellular norepinephrine and absence of sensitization and cross-sensitization to methamphetamine. J. Neurosci. 22 (2002) 7264-7271
33. Lehmann K., Lesting J., Polascheck D., and Teuchert-Noodt G. Serotonin fibre densities in subcortical areas: differential effects of isolated rearing and methamphetamine. Brain Res. Dev. Brain Res. 147 (2003) 143-152
34. Lehmann K., Hundsdorfer B., Hartmann T., and Teuchert-Noodt G. The acetylcholine fiber density of the neocortex is altered by isolated rearing and early methamphetamine intoxication in rodents. Exp. Neurol. 189 (2004) 131-140
35. Lesting J., Neddens J., Busche A., and Teuchert-Noodt G. Hemisphere-specific effects on serotonin but not dopamine innervation in the nucleus accumbens of gerbils caused by isolated rearing and a single early methamphetamine challenge. Brain Res. 1035 (2005) 168-176
36. Lidow M.S., and Song Z.M. Primates exposed to cocaine in utero display reduced density and number of cerebral cortical neurons. J. Comp. Neurol. 435 (2001) 263-275
37. Marrocco R.T., Witte E.A., and Davidson M.C. Arousal systems. Curr. Opin. Neurobiol. 4 (1994) 166-170
38. McGaugh J.L. The amygdala modulates the consolidation of memories of emotionally arousing experiences. Annu. Rev. Neurosci. 27 (2004) 1-28
39. Miller K.J., and Castellanos F.X. Attention deficit/hyperactivity disorders. Pediatr. Rev. 19 (1998) 373-384
40. Mogenson G.J., Jones D.L., and Yim C.Y. From motivation to action: functional interface between the limbic system and the motor system. Prog. Neurobiol. 14 (1980) 69-97
41. Moll G.H., Hause S., Ruther E., Rothenberger A., and Huether G. Early methylphenidate administration to young rats causes a persistent reduction in the density of striatal dopamine transporters. J. Child Adolesc. Psychopharmacol. 11 (2001) 15-24
42. Nakamura S. Axonal sprouting of noradrenergic locus coeruleus neurons following repeated stress and antidepressant treatment. Prog. Brain Res. 88 (1991) 587-598
43. Neddens J., Lesting J., Dawirs R.R., and Teuchert-Noodt G. An early methamphetamine challenge suppresses the maturation of dopamine fibres in the nucleus accumbens of gerbils: on the significance of rearing conditions. J. Neural Transm. 109 (2002) 141-155
44. Neddens J., Bagorda F., Busche A., Horstmann S., Moll G.H., Dawirs R.R., and Teuchert-Noodt G. Epigenetic factors differentially influence postnatal maturation of serotonin (5-HT) innervation in cerebral cortex of gerbils: interaction of rearing conditions and early methamphetamine challenge. Brain Res. Dev. Brain Res. 146 (2003) 119-130
45. Neddens J., Dawirs R.R., Bagorda F., Busche A., Horstmann S., and Teuchert-Noodt G. Postnatal maturation of cortical serotonin lateral asymmetry in gerbils is vulnerable to both environmental and pharmacological epigenetic challenges. Brain Res. 1021 (2004) 200-208
46. Nossoll M., Teuchert-Noodt G., and Dawirs R.R. A single dose of methamphetamine in neonatal gerbils affects adult prefrontal gamma-aminobutyric acid innervation. Eur. J. Pharmacol. 340 (1997) R3-R5
47. Oades R.D., Sadile A.G., Sagvolden T., Viggiano D., Zuddas A., Devoto P., Aase H., Johansen E.B., Ruocco L.A., and Russell V.A. The control of responsiveness in ADHD by catecholamines: evidence for dopaminergic, noradrenergic and interactive roles. Dev. Sci. 8 (2005) 122-131
48. Papa M., Sellitti S., and Sadile A.G. Remodeling of neural networks in the anterior forebrain of an animal model of hyperactivity and attention deficits as monitored by molecular imaging probes. Neurosci. Biobehav. Rev. 24 (2000) 149-156
49. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (1986), Academic Press, New York
50. Pitkanen A. Connectivity of the rat amygdaloid complex. In: Aggleton J.P. (Ed). The Amygdala (2000), Oxford university Press, New York 31-116
51. Posner M.I., and Dehaene S. Attentional networks. Trends Neurosci. 17 (1994) 75-79
52. Robbins T.W., and Everitt B.J. Neurobehavioural mechanisms of reward and motivation. Curr. Opin. Neurobiol. 6 (1996) 228-236
53. Snow D.M., Smith J.D., Booze R.M., Welch M.A., and Mactutus C.F. Cocaine decreases cell survival and inhibits neurite extension of rat locus coeruleus neurons. Neurotoxicol. Teratol. 23 (2001) 225-234
54. Solanto M.V. Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration. Behav. Brain Res. 94 (1998) 127-152
55. Sowell E.R., Thompson P.M., Welcome S.E., Henkenius A.L., Toga A.W., and Peterson B.S. Cortical abnormalities in children and adolescents with attention-deficit hyperactivity disorder. Lancet 362 (2003) 1699-1707
56. Spencer T., Biederman J., Wilens T., Harding M., O'Donnell D., and Griffin S. Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle. J. Am. Acad. Child Adolesc. Psych. 35 (1996) 409-432
57. Srinivas N.R., Hubbard J.W., Korchinski E.D., and Midha K.K. Enantioselective pharmacokinetics of dl-threo-methylphenidate in humans. Pharm. Res. 10 (1993) 14-21
58. Swanson J.M., Sergeant J.A., Taylor E., Sonuga-Barke E.J., Jensen P.S., and Cantwell D.P. Attention-deficit hyperactivity disorder and hyperkinetic disorder. Lancet 351 (1998) 429-433
59. Valverde F. Golgi Atlas of the Postnatal Mouse Brain (1998), Springer-Verlag, Wien
60. Vincent S.L., Adamec E., Sorensen I., and Benes F.M. The effects of chronic haloperidol administration on GABA-immunoreactive axon terminals in rat medial prefrontal cortex. Synapse 17 (1994) 26-35
61. Vitiello B. Psychopharmacology for young children: clinical needs and research opportunities. Pediatrics 108 (2001) 983-989
62. Volkow N.D., and Insel T.R. What are the long-term effects of methylphenidate treatment?. Biol. Psychiatry 54 (2003) 1307-1309
63. Volkow N.D., Wang G.J., Fowler J.S., Gatley S.J., Logan J., Ding Y.S., Hitzemann R., and Pappas N. Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. Am. J. Psychiatry 155 (1998) 1325-1331
64. Volkow N.D., Wang G., Fowler J.S., Logan J., Gerasimov M., Maynard L., Ding Y., Gatley S.J., Gifford A., and Franceschi D. Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain. J. Neurosci. 21 (2001) RC121
65. Wegerer V., Moll G.H., Bagli M., Rothenberger A., Ruther E., and Huether G. Persistently increased density of serotonin transporters in the frontal cortex of rats treated with fluoxetine during early juvenile life. J. Child Adolesc. Psychopharmacol. 9 (1999) 13-24